Adage Capital Partners GP »

Aeglea Biotherapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $42M 1.1M 37.93

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Aeglea Biotherapeutics

FMR
Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Adage Capital Partners GP
Franklin Resources
Citadel Advisors
Wellington Management Company
BlackRock
Braidwell
Vanguard Group
Darwin Global Management
Farallon Capital Management
First Turn Management

View all funds holding Aeglea Biotherapeutics